Viewing Study NCT06855095


Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2025-12-24 @ 1:16 PM
Study NCT ID: NCT06855095
Status: RECRUITING
Last Update Posted: 2025-03-03
First Post: 2023-10-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
Sponsor: The Netherlands Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module